HOOKIPA PHARMA INC (HOOK) Stock Fundamental Analysis
NASDAQ:HOOK - US43906K2096 - Common Stock
0.8403 USD
-0.06 (-6.92%)
0.83 USD
-0.01 (-1.23%)
We assign a fundamental rating of 3 out of 10 to HOOK. HOOK was compared to 549 industry peers in the Biotechnology industry. While HOOK has a great health rating, there are worries on its profitability. HOOK does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
HOOK had negative earnings in the past year.
In the past year HOOK has reported a negative cash flow from operations.
In the past 5 years HOOK always reported negative net income.
HOOK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
HOOK has a worse Return On Assets (-119.68%) than 79.89% of its industry peers.
HOOK has a worse Return On Equity (-215.12%) than 68.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -119.68% | ||
| ROE | -215.12% | ||
| ROIC | N/A |
ROA(3y)-47.11%
ROA(5y)-44.97%
ROE(3y)-79.69%
ROE(5y)-70.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for HOOK so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
HOOK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HOOK has about the same amount of shares outstanding.
Compared to 5 years ago, HOOK has less shares outstanding
HOOK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -12.59, we must say that HOOK is in the distress zone and has some risk of bankruptcy.
HOOK has a Altman-Z score of -12.59. This is in the lower half of the industry: HOOK underperforms 77.36% of its industry peers.
There is no outstanding debt for HOOK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -12.59 |
ROIC/WACCN/A
WACC9.58%
2.3 Liquidity
HOOK has a Current Ratio of 3.61. This indicates that HOOK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.61, HOOK is in line with its industry, outperforming 42.75% of the companies in the same industry.
HOOK has a Quick Ratio of 3.61. This indicates that HOOK is financially healthy and has no problem in meeting its short term obligations.
HOOK has a Quick ratio (3.61) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.61 |
3. Growth
3.1 Past
HOOK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.80%.
Looking at the last year, HOOK shows a very negative growth in Revenue. The Revenue has decreased by -82.54% in the last year.
The Revenue has been growing by 29.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-16.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.82%
Revenue 1Y (TTM)-82.54%
Revenue growth 3Y33.55%
Revenue growth 5Y29.77%
Sales Q2Q%-94.52%
3.2 Future
Based on estimates for the next years, HOOK will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.32% on average per year.
Based on estimates for the next years, HOOK will show a very negative growth in Revenue. The Revenue will decrease by -16.44% on average per year.
EPS Next Y24.44%
EPS Next 2Y24.37%
EPS Next 3Y17.85%
EPS Next 5Y8.32%
Revenue Next Year-49.08%
Revenue Next 2Y-85.73%
Revenue Next 3Y-41.16%
Revenue Next 5Y-16.44%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for HOOK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HOOK. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as HOOK's earnings are expected to grow with 17.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.37%
EPS Next 3Y17.85%
5. Dividend
5.1 Amount
No dividends for HOOK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.8403
-0.06 (-6.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners34.13%
Inst Owner Change-3.22%
Ins Owners0.05%
Ins Owner Change-0.19%
Market Cap10.25M
Analysts45.71
Price Target29.07 (3359.48%)
Short Float %0.08%
Short Ratio0.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-128.61%
Min EPS beat(2)-241.28%
Max EPS beat(2)-15.95%
EPS beat(4)1
Avg EPS beat(4)-65.15%
Min EPS beat(4)-241.28%
Max EPS beat(4)15.62%
EPS beat(8)3
Avg EPS beat(8)-6.22%
EPS beat(12)6
Avg EPS beat(12)0.49%
EPS beat(16)7
Avg EPS beat(16)-4.9%
Revenue beat(2)0
Avg Revenue beat(2)-60.69%
Min Revenue beat(2)-79.59%
Max Revenue beat(2)-41.79%
Revenue beat(4)0
Avg Revenue beat(4)-57.44%
Min Revenue beat(4)-82.17%
Max Revenue beat(4)-26.23%
Revenue beat(8)3
Avg Revenue beat(8)127.91%
Revenue beat(12)4
Avg Revenue beat(12)79.48%
Revenue beat(16)6
Avg Revenue beat(16)52.08%
PT rev (1m)0%
PT rev (3m)44.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.61%
EPS NY rev (1m)0%
EPS NY rev (3m)0.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)29.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.1 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.3 | ||
| P/tB | 0.3 | ||
| EV/EBITDA | N/A |
EPS(TTM)-5.84
EYN/A
EPS(NY)-1.59
Fwd EYN/A
FCF(TTM)-4.33
FCFYN/A
OCF(TTM)-4.33
OCFYN/A
SpS0.77
BVpS2.79
TBVpS2.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -119.68% | ||
| ROE | -215.12% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-47.11%
ROA(5y)-44.97%
ROE(3y)-79.69%
ROE(5y)-70.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 3.92% | ||
| Cap/Sales | 1.05% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.61 | ||
| Altman-Z | -12.59 |
F-Score2
WACC9.58%
ROIC/WACCN/A
Cap/Depr(3y)87.86%
Cap/Depr(5y)118.36%
Cap/Sales(3y)18.78%
Cap/Sales(5y)27.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.82%
EPS Next Y24.44%
EPS Next 2Y24.37%
EPS Next 3Y17.85%
EPS Next 5Y8.32%
Revenue 1Y (TTM)-82.54%
Revenue growth 3Y33.55%
Revenue growth 5Y29.77%
Sales Q2Q%-94.52%
Revenue Next Year-49.08%
Revenue Next 2Y-85.73%
Revenue Next 3Y-41.16%
Revenue Next 5Y-16.44%
EBIT growth 1Y-50.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-105.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-88.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.69%
OCF growth 3YN/A
OCF growth 5YN/A